Target intelligence / Profile preview

Rod-specific cGMP phosphodiesterase 6 (PDE6)

Target
PDE6
Molecular classification
Enzyme, Phosphodiesterase, cGMP-specific phosphodiesterase
01

Overview

Rod-specific cGMP phosphodiesterase 6 (PDE6) is a key enzyme in the visual phototransduction cascade, primarily located in the outer segments of rod photoreceptor cells. It exists as a heterotetrameric complex consisting of two catalytic subunits (alpha and beta) and two inhibitory gamma subunits. Upon light stimulation, the G-protein transducin activates PDE6, which then rapidly hydrolyzes cyclic guanosine monophosphate (cGMP) to 5'-GMP. This decrease in cGMP levels leads to the closure of cGMP-gated cation channels, resulting in cell hyperpolarization and the transmission of visual signals to the brain. Mutations in the genes encoding its subunits (PDE6A, PDE6B, or PDE6G) are a major cause of autosomal recessive retinitis pigmentosa, a degenerative eye disease characterized by night blindness and progressive peripheral vision loss. Additionally, PDE6 is a significant off-target for phosphodiesterase 5 (PDE5) inhibitors like sildenafil, which can cause transient visual disturbances due to their structural similarity to the PDE6 catalytic site.

Other names
PDE6APDE6BPDE6GRod-specific cGMP phosphodiesterasecGMP-specific 3',5'-cyclic phosphodiesteraseRod photoreceptor phosphodiesterase
02

Mechanism of action

Phosphodiesterase inhibition; Gene supplementation

03

Biological functions

PhototransductionSignal transductioncGMP hydrolysisVisual cycleRegulation of rod cell hyperpolarization
04

Disease associations

Retinitis pigmentosaCongenital stationary night blindnessRod-cone dystrophy
05

Safety considerations

Visual disturbances (cyanopsia/blue-tinted vision)Blurred visionPhotophobiaRetinal thinningTransient electroretinogram (ERG) alterations
06

Interacting drugs

Sildenafil

6 more in the full profile.

07

Biomarkers

Electroretinography (ERG)PDE6A mutationPDE6B mutationPDE6G mutationRetinal thickness (Optical Coherence Tomography)Best corrected visual acuity (BCVA)

Beyond the preview

Go deeper on Rod-specific cGMP phosphodiesterase 6 (PDE6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rod-specific cGMP phosphodiesterase 6 (PDE6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call